Schwartz Aharon

Schwartz Aharon is listed in filings as Director at Protalix BioTherapeutics, Inc.. This profile follows SEC Form 4 activity through Sep 4, 2025, including purchase activity. Recent filings connect the profile to Protalix BioTherapeutics, Inc. (PLX). The current snapshot covers public activity from Aug 12, 2025 to Sep 4, 2025. Reported amounts are shown as $24.6K to $205.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.